A newly published report by Market Statsville Group (MSG), titled [URL=https://www.marketstatsville.com/anti-infectives-market]Anti-infectives Market[/URL] provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Anti-infectives market will showcase an impressive CAGR from 2024 to 2033. This report contains the historic, present, and forecast analysis of the Anti-infectives market at segmental, regional, and country-level, including the following market information:
• Global Anti-infectives Market Revenue, 2018-2023, 2024-2033, (US$ Millions)
• Global Anti-infectives Market Sales Volume, 2018-2023, 2024-2033, (Units)
• Share of the top five Anti-infectives companies in 2023 (%)
Request Sample Copy of this Report: [FURL]https://www.marketstatsville.com/request-sample/anti-infectives-market?utm_source=Manjeet+briefingwire+23+may&utm_medium=Manjeet[/FURL]
Anti-infectives Market Segments Covered in this report are:
Based on product, the anti-infectives market has been segmented into –
• Antibiotics
• Antivirals
• Antifungals
• Others
Based on indication, the anti-infectives market has been segmented into-
• HIV Infection
• Pneumonia
• Respiratory Virus Infection
• Sepsis
• Tuberculosis
• Others
Based on distribution channel, the anti-infectives market has been segmented into-
• Hospital Pharmacy
• Retail Pharmacy
• Others
Based on route of administration, the anti-infectives market has been segmented into-
• Oral
• Topical
• Parenteral
• Others
Based on range, the anti-infectives market has been segmented into-
• Narrow Spectrum
• Broad Spectrum
Based on end-users, the anti-infectives market has been segmented into-
• Hospitals
• Homecare
• Specialty Clinics
• Others
Anti-infectives Market Regional Analysis in the report covers:
North America (Revenue: USD Million; 2018-2033)
• US
• Canada
• Mexico
Europe (Revenue: USD Million; 2018-2033)
• Germany
• France
• U.K.
• Italy
• Spain
• Russia
• The Netherland
• Poland
• Belgium
• Nordic Countries
• Rest of Europe
Asia Pacific (Revenue: USD Million; 2018-2033)
• China
• Japan
• South Korea
• ASEAN
• Australia & New Zealand
• India
• Rest of Asia
South America (Revenue: USD Million; 2018-2033)
• Brazil
• Argentina
• Peru
• Colombia
• Rest of South America
Middle East & Africa (Revenue: USD Million; 2018-2033)
• Turkey
• Israel
• Saudi Arabia
• Egypt
• UAE
• Rest of the Middle East & Africa
The key companies covered in the market report are:
• Abbott Laboratories Limited
• Cipla Ltd.
• Claris Life Sciences Ltd.
• Glenmark Pharmaceuticals Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• Lupin Ltd.
• Panacea Biotech Ltd.
• Novartis AG
• Pfizer Ltd.
• Ranbaxy Laboratories Ltd.
• Sun Pharmaceuticals Ltd.